CHEN Jue, ZHOU Wenlan, CHEN Huiping, ZHU Weigang, LIN Huaide, LI Dangsheng, LU Chunfen, SHEN Yuqing. Practice and exploration of traditional Chinese medicine in real-world treatment of novel coronavirus pneumonia in a grass-roots designated hospital[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 5-9. DOI: 10.7619/jcmp.202004002
Citation: CHEN Jue, ZHOU Wenlan, CHEN Huiping, ZHU Weigang, LIN Huaide, LI Dangsheng, LU Chunfen, SHEN Yuqing. Practice and exploration of traditional Chinese medicine in real-world treatment of novel coronavirus pneumonia in a grass-roots designated hospital[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 5-9. DOI: 10.7619/jcmp.202004002

Practice and exploration of traditional Chinese medicine in real-world treatment of novel coronavirus pneumonia in a grass-roots designated hospital

More Information
  • Received Date: February 15, 2020
  • Available Online: August 26, 2020
  • During the outbreak period of novel coronavirus pneumonia, our hospital actively applied the method of integrated traditional Chinese medicine(TCM)and western medicine for prevention and treatment based on national guidelines. During the course of syndrome differentiation and treatment on etiology and pathogenesis of the disease, we realized that novel coronavirus pneumonia was classified as "cold-damp epidemic" in view of traditional Chinese medicine, and the specific pathogenesis was cold-damp epidemic pathogen obstructed in spleen and lung. With the development of the disease, cold and dampness may change into heat. The disease was located at lung and spleen. In the treatment, the patients with dominant lung syndrome were classified as lung type, and the patients with dominant spleen syndrome were classified as spleen type. The treatment principles of suiting measures to local conditions, dispersing the lung by drugs with pungent flavor and warm texture as well as refreshing the spleen by drugs with fragrant flavor were adopted according to the different types, and we do achieved good results in prevention and treatment. This study not only inherits the thought of syndrome differentiation of TCMin treating severe epidemic disease, but also explores new attempts and innovation, especially in simplified staging and types, which improves participation of TCMin treating epidemic disease,and is more convenient to apply in grass-roots hospitals in practice.
  • 中华人民共和国中央人民政府. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知(国卫办医函〔2020〕103号)[EB/OL]. http://www.gov.cn/zhuanti/2020-02/05/content_5474791.htm.
    李晓凤, 杜武勋. 基于五运六气理论对新型冠状病毒感染的肺炎的几点思考[J/OL]. 中华中医药学刊. http://kns.cnki.net/kcms/detail/21.1546.R.20200206.1811.002.html.
    范伏元, 樊新荣, 王莘智. 从“湿毒夹燥”谈湖南新型冠状病毒感染的肺炎的中医特点及防治[J/OL]. 中医杂志. http://kns.cnki.net/kcms/detail/11.2166.r.20200206.1256.004.html.
    刘清泉, 夏文广, 张伯礼. 中西医结合治疗新型冠状病毒肺炎作用的思考[J/OL]. 中医杂志. http://kns.cnki.net/kcms/detail/11.2166.R.20200215.1057.002.html.
    陈瑞, 罗亚萍, 徐勋华, 等. 基于武汉地区52例新型冠状病毒肺炎的中医证治初探及典型病案分析[J/OL]. 中医杂志. http://kns.cnki.net/kcms/detail/11.2166.R.20200220.

    1443.002.html.
    夏文广, 安长青, 张伯礼. 中西医结合治疗新型冠状病毒肺炎34例临床研究[J/OL]. 中医杂志. http://kns.cnki.net/kcms/detail/11.2166.R.20200217.

    1502.004. html.
    薛博瑜. 新型冠状病毒肺炎的中医药辨治思路[J/OL]. 南京中医药大学学报. http://kns.cnki.net/kcms/detail/32.1247.R.20200218.0823.002.html.
    薛伯寿, 姚魁武, 薛燕星. 清肺排毒汤快速有效治疗新型冠状病毒肺炎的中医理论分析[J/OL]. 中医杂志. http://kns.cnki.net/kcms/detail/11.2166.R.20200216.2004.002.html.
  • Related Articles

    [1]MING Ni, LIU Zhi, WU Haihui, ZHANG Guigui, LIU Lihua. Comparison of magnesium sulfate and nifedipineon hemodynamics and pregnancy outcomes of pregnant woman with hypertensive disorders complicating pregnancy[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 84-87. DOI: 10.7619/jcmp.20221234
    [2]QIU Yongjun, WANG Fang, QIU Zaijun. Predictive model of adverse reactions of initial application of magnesium sulfate injection in patients with threatened abortion or premature delivery[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 63-67. DOI: 10.7619/jcmp.20214753
    [3]GUO Haiyan, YANG Haoran, SHI Huilian, LIU Lina, CHE Junyong. Magnesium isoglycyrrhizinate versus compound glycyrrhizin in treatment of patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 36-39. DOI: 10.7619/jcmp.20211632
    [4]LYU Xin, ZHANG Xiangjun. Effect of somatostatin combined with magnesium sulfate in treatment of severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 28-31. DOI: 10.7619/jcmp.202022008
    [5]XU Jingning, XU Lin, LIU Jinjun. Effect of labetalol combined with magnesium sulfate in the treatment of pregnancy-induced hypertension and its effect on outcomes of childbirth[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 87-89,93. DOI: 10.7619/jcmp.202020024
    [6]YANG Jing, YANG Yongkang, ZHANG Miaofang, LIU Pei. Effects of magnesium sulfate monotherapy and its combination with labetalol on hemorheological parameters in patients with pregnancy-induced hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 45-49. DOI: 10.7619/jcmp.202004011
    [7]ZHONG Yuquan, ZHANG Xu. Influence of magnesium sulfate on levels of serum C-reactive protein, bilirubin and gastrointestinal function in patients with calculous cholecystitis[J]. Journal of Clinical Medicine in Practice, 2016, (23): 40-42,53. DOI: 10.7619/jcmp.201623012
    [8]PAN Xiaojie, LIU Hongxian, LIANG Min. Correction between the serum trace elements,peripheral blood T lymphocyte subsets and children with recurrent respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2014, (7): 51-53. DOI: 10.7619/jcmp.201407015
    [9]Efficacy and influence of serum IgE of magnesium isoglycyrrhizinate in the treatment of chronic urticaria[J]. Journal of Clinical Medicine in Practice, 2013, (14): 97-98,101. DOI: 10.7619/jcmp.201314034
  • Cited by

    Periodical cited type(9)

    1. 曲振廷,叶关毅,李环,徐小磊,李素芬. 归脾汤加减治疗儿童学习困难型多动症的临床研究. 吉林医药学院学报. 2024(03): 200-203 .
    2. 张倩,刘广华,何月敏,谢晓颖,徐乐瑶. 整合心理行为干预对多动症患儿认知功能及P300的影响. 中国基层医药. 2024(06): 885-889 .
    3. 苑成浩,杨丽,李明,刘晓亮. 调神益智汤联合生物反馈对学龄期多动症患儿血清ACTH、CORT水平的影响. 四川中医. 2024(07): 129-132 .
    4. 钦云峰,凌寅杰,袁琛. 脑蛋白水解物联合盐酸托莫西汀治疗小儿多动症的效果观察及对患儿认知功能的影响. 中国妇幼保健. 2024(17): 3327-3331 .
    5. 巫慧敏,任妍,朱帝玲,陈月,张素华,秦成洁,罗映娟,杨柳. 四川省成都市42679名学龄前儿童中注意缺陷多动障碍现状调研及影响因素分析. 实用临床医药杂志. 2023(08): 62-66 . 本站查看
    6. 赵云鹏,白光磊,梁力泳. 自拟清心补气平肝汤联合盐酸托莫西汀治疗注意缺陷多动障碍的临床研究. 国际中医中药杂志. 2023(06): 684-688 .
    7. 张雪宁,谢振中,庞玉兰. 注意缺陷多动障碍患儿肠道细菌构成特点及临床意义. 中国妇幼保健. 2023(14): 2593-2596 .
    8. 李辉. 不同严重程度多动症儿童的血清NE和DA水平及其影响因素分析. 中国处方药. 2023(10): 169-171 .
    9. 徐晓慧. 分析3~10岁儿童注意缺陷多动症状的发生状况及其与睡眠的关系. 世界睡眠医学杂志. 2023(10): 2350-2352 .

    Other cited types(3)

Catalog

    Article views (409) PDF downloads (10) Cited by(12)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return